Massachusetts Financial Services
CRL icon

Massachusetts Financial Services’s Charles River Laboratories CRL Stock Holding History

Massachusetts Financial Services’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$299M Buy
1,000,635
+318,462
+47% +$83.9M 0.1% 194
2026
Q2 		$158M Sell
682,173
-226,677
-25% -$40.4M 0.05% 316
2026
Q1 		$159M Buy
908,850
+24,159
+3% +$4.48M 0.05% 289
2025
Q4 		$176M Buy
+884,691
New +$160M 0.06% 293
2022
Q4 		– Sell
-270,130
Closed -$53.2M – 853
2022
Q3 		$53.2M Sell
270,130
-590,305
-69% -$127M 0.02% 430
2022
Q2 		$184M Sell
860,435
-281,787
-25% -$68.9M 0.06% 259
2022
Q1 		$324M Sell
1,142,222
-149,893
-12% -$46.2M 0.1% 191
2021
Q4 		$487M Sell
1,292,115
-65,131
-5% -$25.3M 0.13% 160
2021
Q3 		$560M Sell
1,357,246
-81,163
-6% -$33.7M 0.16% 145
2021
Q2 		$532M Buy
1,438,409
+59,970
+4% +$20M 0.16% 152
2021
Q1 		$400M Buy
1,378,439
+6,689
+0.5% +$1.86M 0.12% 167
2020
Q4 		$343M Buy
1,371,750
+103,869
+8% +$24.7M 0.11% 179
2020
Q3 		$287M Buy
1,267,881
+409,339
+48% +$85M 0.1% 186
2020
Q2 		$150M Buy
858,542
+269,611
+46% +$43M 0.06% 254
2020
Q1 		$74.3M Buy
588,931
+352,637
+149% +$52.9M 0.04% 314
2019
Q4 		$36.1M Buy
236,294
+7,247
+3% +$1M 0.01% 455
2019
Q3 		$30.3M Buy
229,047
+54,841
+31% +$7.35M 0.01% 472
2019
Q2 		$24.7M Buy
174,206
+16,211
+10% +$2.2M 0.01% 510
2019
Q1 		$22.9M Sell
157,995
-25,959
-14% -$3.41M 0.01% 511
2018
Q4 		$20.8M Sell
183,954
-64,957
-26% -$8.13M 0.01% 497
2018
Q3 		$33.5M Buy
248,911
+46,195
+23% +$5.7M 0.01% 457
2018
Q2 		$22.8M Buy
202,716
+79,619
+65% +$8.61M 0.01% 494
2018
Q1 		$13.1M Buy
+123,097
New +$13.3M 0.01% 576

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ariel Investments
Ariel Investments Chicago, Illinois $9.6B AUM 22.21% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $25.4B AUM 35.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 20.64% 1-Year Est. Return

Massachusetts Financial Services's CRL Position: Q3 2026 in Review

Massachusetts Financial Services increased its Charles River Laboratories (CRL) stake by 47% in Q3 2026, buying an estimated $83.9M and bringing the position to 1,000,635 shares worth $299M. The position accounts for 0.1% of the portfolio, ranked #194.

Massachusetts Financial Services first reported a position in CRL in Q1 2018 and has held it in 23 quarters since. The position peaked at $560M in Q3 2021. 449 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Massachusetts Financial Services held 1,000,635 shares of Charles River Laboratories worth $299M as of Q3 2026.
  • Massachusetts Financial Services bought 318,462 Charles River Laboratories shares in Q3 2026, an estimated $83.9M.
  • Charles River Laboratories made up 0.1% of Massachusetts Financial Services's portfolio in Q3 2026, its #194 holding.
  • Massachusetts Financial Services first reported a position in Charles River Laboratories in Q1 2018 and has held it in 23 quarters since.
  • Massachusetts Financial Services's Charles River Laboratories position peaked at $560M in Q3 2021.
  • 449 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Massachusetts Financial Services's 13F filing for Q3 2026, filed 12 Nov 2026.